Epigenetics Drugs and Diagnostic Technologies Market
According to Intent Market Research, the Epigenetics Drugs and Diagnostic Technologies Market is expected to grow from USD 14.2 billion in 2023 at a CAGR of 14.6% to touch USD 37.0 billion by 2030. The Epigenetics Drugs and Diagnostic Technologies Market is dominated by key players such as Thermo Fisher Scientific, Illumina, Inc., Roche Diagnostics, Novartis AG, GSK (GlaxoSmithKline), Merck & Co., Inc., AbbVie Inc., Pfizer Inc., AstraZeneca PLC, Epigenomics AG, Zymo Research Corp., Agilent Technologies, Bio-Rad Laboratories, Inc., Takara Bio, Inc., F. Hoffmann-La Roche Ltd.